RPS10P5 in Cancer, Neurodegenerative Disorders and Developmental Delays

Target Name: RPS10P5

NCBI ID: G93144

RPS10P5

Other Name(s): RPS10L | RPS10_13_1677 | bA371L19.2 | Ribosomal protein S10 pseudogene 5 | ribosomal protein S10 pseudogene 5

RPS10P5 in Cancer, Neurodegenerative Disorders and Developmental Delays

Ribosome protein S1 (RPS1) is a key regulator of protein synthesis in eukaryotic cells. It plays a crucial role in ensuring the accuracy, efficiency, and quality of the proteins produced by the cell. Mutations in the RPS1 gene have been linked to various diseases , including cancer, neurodegenerative disorders, and developmental delays.

The protein encoded by the RPS1 gene, RPS10P5 (RPS10L), has been identified as a potential drug target or biomarker for various diseases. In this article, we will discuss the structure, function, and potential therapeutic applications of RPS10P5.

Structure and Expression

RPS10P5 is a 21-kDa protein that contains 10 distinct amino acid residues. It is expressed in a variety of tissues and cells, including muscle, heart, brain, and cancer cells. RPS10P5 is predominantly localized to the endoplasmic reticulum (ER) and cytoplasm , with smaller amounts detected in the nuclear pore.

Function

RPS10P5 is involved in the regulation of protein synthesis by binding to specific target proteins and affecting their stability. Several studies have demonstrated that RPS10P5 can interact with various proteins, including ribosomes, poly(A) polymerase (PAP), and the protein of the 26S ribosome. These interactions are critical for the regulation of protein synthesis accuracy, stability, and quality.

One of the most significant functions of RPS10P5 is its role in the regulation of the fidelity of protein synthesis. Studies have shown that RPS10P5 can interact with the rRNA chain of the 26S ribosome and enhance its stability. This interaction between RPS10P5 and the ribosome is critical for the accurate and efficient production of proteins with the desired quality and stability.

In addition to its role in protein synthesis regulation, RPS10P5 has also been shown to play a role in the regulation of post-translational modification (PTM) of proteins. Studies have demonstrated that RPS10P5 can interact with various PTM-modifying enzymes, including tyrosine phosphorylase (TPL) and mode protein (PSP). These interactions are critical for the regulation of protein stability, localization, and interaction with other cellular components.

Potential Therapeutic Applications

The therapeutic potential applications of RPS10P5 are vast and varied. One of the most promising applications is its potential as a drug target for various diseases, including cancer, neurodegenerative disorders, and developmental delays.

In cancer, RPS10P5 has been shown to play a role in the regulation of cell growth, apoptosis, and angiogenesis. Many studies have demonstrated that RPS10P5 can inhibit the translation of cancer-promoting mutants into viable cells. This has led to the speculation that RPS10P5 may be an effective drug target for cancer treatment.

In neurodegenerative disorders, RPS10P5 has been shown to play a role in the regulation of protein synthesis and localization of neurotransmitter-producing neurons. This has led to the hypothesis that RPS10P5 may be an effective drug target for the treatment of neurodegenerative disorders.

In developmental delays, RPS10P5 has been shown to play a role in the regulation of protein synthesis and localization of neuronal axons. This has led to the hypothesis that RPS10P5 may be an effective drug target for the treatment of developmental delays.

Conclusion

In conclusion, RPS10P5 is a protein that has significant involvement in the regulation of protein synthesis and post-translational modification in eukaryotic cells. Its functions as a drug target or biomarker make it an attractive target for the development of new therapeutic agents for various diseases, including cancer, neurodegenerative disorders, and developmental delays. Further research is needed to fully understand the role of RPS10P5 in

Protein Name: Ribosomal Protein S10 Pseudogene 5

The "RPS10P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS10P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets